The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.
There are four major factors that are impacting the value creation in pharmaceutical industry:
Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases
Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.
The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.
Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.
Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.
Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.
Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.
Growth in Emerging Economies
The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.
Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.
There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.
The global halal nutraceuticals and vaccines market is estimated to be valued at US$ 64.48 billion in 2023 and is expected to exhibit a CAGR of 7.35% during the forecast period (2023-2030).... View more
Pemirolast is a mast cell stabilizer, which acts as an anti-allergic agent. Pemirolast treats allergic reactions by preventing mast cell degranulation, which stabilizes the mast cell and inhibits the release of inflammatory mediators such as histamines and leukotriene... View more
Tumor Necrosis Factor (TNF) inhibitors are class of medications used for the management of inflammatory arthritis. These target the TNF- alpha, a component of the immune system that is responsible for inflammation in the body. Currently, five inhibitors are available ... View more
Synthetic hormones are foreign substances, synthesized in the laboratory and are used for the treatment of hormonal imbalance in the human body. Hormones such as progesterone, estrogen, thyroid hormone, testosterone, and insulin are some of the synthetic hormones used... View more
Trypsin is a serine protease enzyme (EC number of 188.8.131.52), which hydrolyses esters of basic amino acids such as lysine and arginine in the peptides. Optimal temperature for trypsin activation is around 37 degrees Celsius and its optimal pH is around 7.5 to 9.0. Tryp... View more
Weight Loss and Obesity Management Market – Market Insights Obesity is defined as excess body fat accumulation. The major factors contributing to obesity throughout the world are diseases and adoption... View more
Intravenous solution is given to patients to replenish the water, sugar, and salt levels in their body in case of an operation or when an individual can’t eat or drink normally. Intravenous solution is also known as intravenous fluids. Intravenous solutions are ... View more
A branded generic is a generic drug that has gone through the Abbreviated New Drug Application (ANDA) process, and is assigned a name other than the chemical name. Branded generics are bioequivalent to original products and are marketed under a company’s brand n... View more
Companion animal vaccines play a crucial role in ensuring longevity, good health and in improving overall productivity of pets in a cost-effective manner. Companion animal vaccines reduce transmission of various diseases from animals to humans. Companion animal vaccin... View more
Zopiclone is a cyclopyrrolone, belongs to the class of psychotherapeutic agents which are generally marketed in the form of pill to treat insomnia. It acts as a γ-amino butyric acid (GABA) agonist and leads to blockage of the signal transmission across nerv... View more
Flavoxate hydrochloride is a muscle relaxant with urinary antispasmodic properties. Flavoxate binds to the muscarinic receptors which suppresses micturition reflex. It helps in modifying micturition center in the brain stem by increasing capacity of the urin... View more
Membranous nephropathy occurs when the blood vessels in the nephron (filters) of the kidney get damaged. This leads to proteinuria, that is, leakage of proteins in the urine due to thickening of the walls of the blood vessels which increase the chances of kidney failu... View more
Common cold spread from person to person through various medium such as cough droplets, sneezes, and mucus in hand. Common factors that cause cold include, seasonal factors, close contact with infected person, smoking and exposure to cigarette smoke, weak immune syste... View more
Physical or psychological factors both can result into sexual dysfunction. In most cases issues with sexual health result from a combination of physical and psychological factors. It is a common health problem in both men and women. Delayed ejaculation, premature ejac... View more
Oxytocic drugs used to stimulate uterine activity. It is also used to control bleeding after childbirth. It is injected into a muscle, or given as an infusion into a vein. Natural oxytocin is prepared by extracting from the pituitary glands of the animals. ... View more
The global tissue glue and bio adhesive sealants market is estimated to be valued at US$ 2,007.6 million in 2023 and is expected to exhibit a CAGR of 8.1% during the forecast period (202... View more
Ephedrine is a decongestant and bronchodilator, used to treat bronchospasms caused due to asthma. The medicine reduces the swelling and constricts the blood vessels in the nasal passages which widens the lung airways and allows the patient to breathe easily. Due to th... View more
Diabetes mellitus, commonly known as diabetes, is a chronic condition, in which the blood glucose levels are higher than the normal range. Diabetes is a disorder where the insulin hormone is either not produced by the pancreas (Type 1) or the body fails to utilize it ... View more
Diabetic retinopathy is one of the complications of diabetes, in which blood vessels in the retina gets damaged due to high blood glucose level. Retina is the light sensitive inner lining at the back of the eye. Diabetic retinopathy mostly affects both the eyes. As di... View more
The global ambulatory surgical center market is estimated to be valued at US$ 96.19 Billion in 2023 and is expected to exhibit a CAGR of 4.2% during the forecast period (2023-2030).... View more